Categories
Tech

Noor Findik

At NOOR FINDIK, we put integrity first.

Our belief in providing the best for our customers derives from this basic philosophy. NOOR FINDIK adheres to highest standards of sustainability, transparency and accountability. We recognize that our responsibilities to our customers include supporting best practices throughout the hazelnut industry. From our own hazelnut garden used to educate farmers and customers to sponsoring sustainable farming campaigns, NOOR FINDIK is at the forefront of advances that yield better quality products.

Categories
Other

Kinnos

Initially developed by Columbia University students inspired to make a difference during the 2014 Ebola outbreak in West Africa, Highlight® was created to address the urgent need to improve disinfection application for both epidemic response and everyday use. Our goal is to empower people to disinfect surfaces with confidence and to provide society with peace of mind through disinfection you can see*.

Categories
Medtech

Eyecool

Categories
Medtech

Brixton

Categories
Medtech

Instylla

Instylla is a privately held company based in Bedford, MA, focused on developing next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis. The company’s first product, Embrace™ Hydrogel Embolic System, is designed for controlled, complete, and persistent embolization in these clinical conditions.

Instylla was founded in 2017 by Incept LLC and is funded by several leading venture capital groups.

Categories
Tech

Augmenix

Augmenix, Inc. is a privately held U.S. company based in the Boston, Massachusetts area focused on the development and commercialization of radiation oncology products using its proprietary hydrogel technology. Focusing initially on protection during prostate radiation therapy, Augmenix next-generation products will address spacing and marking applications throughout the body to improve radiotherapy and interventional oncology procedure outcomes. The company’s lead product, SpaceOAR System, is FDA cleared and is currently being used in the majority of leading cancer centers in the United States. It is also CE marked, approved in Australia and licensed in Canada. SpaceOAR is a registered trademark of Augmenix, Inc. More information about Augmenix and the SpaceOAR hydrogel can be found at www.augmenix.com

Categories
Medtech

Roadsync

RoadSync is designed for stress-free logistics payments. Drive your business forward with fast, easy digital solutions.

Top